Sputnik V: How effective is Russia's Covid jab compared to Oxford, Pfizer and Moderna vaccines - and has UK bought any?

By Matt Brooks
Published 2nd Feb 2021, 16:01 BST
Updated 2nd Feb 2021, 16:09 BST

This article contains affiliate links. We may earn a small commission on items purchased through this article, but that does not affect our editorial judgement.

Clinical trials to test efficacy of combined two stage dose of Sputnik V and Oxford jabs is set to begin, Russian vaccine backers say

The world's fight to end the coronavirus pandemic received another boost as Russia's Sputnik V vaccine produced "encouraging" efficacy results from interim trials.

Russia was criticised in some scientific circles last year when it approved the Sputnik V rollout for public use in August before late trials had been completed.

Hide Ad
Hide Ad

The Sputnik vaccine has since been administered to more than two million people worldwide and has been approved in more than 15 countries, ahead of interim results being published.

Russia's Sputnik V jab has shown "encouraging" interim trial efficacy data, published in The Lancet. (Pic: Shutterstock)Russia's Sputnik V jab has shown "encouraging" interim trial efficacy data, published in The Lancet. (Pic: Shutterstock)
Russia's Sputnik V jab has shown "encouraging" interim trial efficacy data, published in The Lancet. (Pic: Shutterstock)
Read More
Vaccine second dose: how long is the gap between the first and second Covid jab ...